People: Akorn Inc (AKRX.O)

AKRX.O on Nasdaq

37.60USD
20 Aug 2014
Price Change (% chg)

$-0.22 (-0.58%)
Prev Close
$37.82
Open
$37.70
Day's High
$37.76
Day's Low
$37.12
Volume
591,186
Avg. Vol
1,088,709
52-wk High
$38.61
52-wk Low
$16.00

Search Stocks

Summary

Name Age Since Current Position

John Kapoor

70 2002 Chairman of the Board

Rajat Rai

47 2010 Chief Executive Officer

Timothy Dick

44 2013 Chief Financial Officer

Bruce Kutinsky

48 2012 Chief Operating Officer

Mark Silverberg

60 2009 Executive Vice President - Global Quality Assurance and Alliance Management

Joseph Bonaccorsi

49 2009 Senior Vice President, General Counsel, Secretary

John Sabat

64 2009 Senior Vice President - National Accounts and Trade Relations

Brian Tambi

68 2009 Director

Kenneth Abramowitz

63 2010 Independent Director

Adrienne Graves

60 2012 Independent Director

Ronald Johnson

68 2003 Independent Director

Steven Meyer

57 2009 Independent Director

Alan Weinstein

71 2009 Independent Director

Chris Hodges

2013 IR Contact Officer

Biographies

Name Description

John Kapoor

Dr. John N. Kapoor, Ph.D. serves as Chairman of the Board of Akorn Inc. Dr. Kapoor served as interim Chief Executive Officer from March 2001 to May 2002 and as Chief Executive Officer from May 2002 to December 2002. Dr. Kapoor is the President of EJ Financial Enterprises, Inc. (a health care consulting and investment company). Dr. Kapoor is the chairman of the board of directors of Insys Therapeutics, a private drug development company focused on pain and oncology, into which NeoPharm, Inc. (previously a publicly held biopharmaceutical company) merged in October 2010. Prior to NeoPharm’s merger, Dr. Kapoor was the chairman of its board of directors.

Rajat Rai

Mr. Rajat Rai serves as Chief Executive Officer of Akorn Inc. Mr. Rai was appointed Interim Chief Executive Officer in June 2009, and appointed Chief Executive Officer in May 2010. He had been appointed Strategic Consultant to the Special Committee of the Board in February 2009, following the departure of company's former President and Chief Executive Officer. Prior to joining Akorn, Mr. Rai was the President and CEO of Option Care, Inc., a provider of home infusion pharmacy and specialty pharmacy services, which was acquired by Walgreen Co. in August 2007. Mr. Rai previously served on the board of directors of SeQual Technologies Inc.

Timothy Dick

Mr. Timothy A. Dick serves as Chief Financial Officer of Akorn Inc. Mr. Dick was appointed Chief Financial Officer in June 2009. Most recently, he was Vice President, Operations Improvement & Analysis of Option Care, Inc., a division of Walgreen Co. Mr. Dick has previously held various leadership positions in the areas of financial planning, analysis, and acquisitions at Option Care, Inc. Prior to joining Option Care, Inc. in September 2001, Mr. Dick held various management positions in finance and acquisitions with both Johnson & Johnson and Peace Health, a Seattle-based regional health care system.

Bruce Kutinsky

Dr. Bruce Kutinsky, Pharm.D., serves as Chief Operating Officer of Akorn Inc. Dr. Kutinsky joined Akorn in late 2009 as Senior Vice President of Corporate Strategy and was named President, Consumer Health Division following the Company’s acquisition of Advanced Vision Research, Inc. in May 2011. In September 2012, Dr. Kutinsky was appointed to serve as Akorn’s Chief Operating Officer. Before joining Akorn, Dr. Kutinsky was Vice President – Strategic Solutions for Walgreens. Prior to that, Dr. Kutinsky served in various roles at Option Care from 1997 to 2007, most recent of which was as Executive Vice President, Specialty Pharmacy. Dr. Kutinsky holds a Doctor of Pharmacy degree from the University of Michigan.

Mark Silverberg

Mr. Mark M. Silverberg serves as Executive Vice President - Global Quality Assurance and Alliance Management of Akorn Inc. Mr. Silverberg served as Senior Vice President, Global Quality Assurance since May 2006. He joined company in April 2005 as Vice President, Global Compliance. Prior to joining, Mr. Silverberg served as Director of Division Quality for the Diagnostics Division of Abbott Laboratories.

Joseph Bonaccorsi

Mr. Joseph P. Bonaccorsi serves as Senior Vice President, General Counsel, Secretary of Akorn Inc. Mr. Bonaccorsi joined Akorn in 2009 as Senior Vice President, Secretary and General Counsel. Mr. Bonaccorsi came to Akorn from Walgreen Co., where he served as Senior Vice President Mergers & Acquisition and Counsel for the Walgreens-Option Care Home Care division. Mr. Bonaccorsi joined Option Care, Inc in 2002, where he served as Senior Vice President, General Counsel, Secretary and Corporate Compliance Officer through 2007. Prior to joining Option Care, Inc., he was in private law practice in Chicago, Illinois. He received his BS degree from Northwestern University and his JD from Loyola University School of Law, Chicago.

John Sabat

Mr. John R. Sabat serves as Senior Vice President - National Accounts and Trade Relations of Akorn Inc. Mr. Sabat assumed the position of Senior Vice President, National Accounts and Trade Relations in June 2009, after serving as Senior Vice President Sales, Marketing and National Accounts since February 2009. He had served as Senior Vice President, National Accounts since October 2004. He joined in June 2003 as Vice President, National Accounts. Prior to joining, he served as Vice President, Sales and Marketing with Pharmaceuticals, a division of Apotex, Inc., and a manufacturer and worldwide distributor of proprietary, multi-source prescription and over-the-counter pharmaceuticals.

Brian Tambi

Mr. Brian Tambi serves as Director of Akorn Inc. Since August 2006, Mr. Tambi has served as the Chairman of the Board, President & CEO of BrianT Laboratories and has been a member of the Board of Directors of Insys Therapeutics since July 2007. From November 1995 to July 2006, Mr. Tambi was the Chairman of the Board, President & CEO of Morton Grove Pharmaceuticals, Inc., a manufacturer and marketer of oral liquid and topical pharmaceuticals. Mr. Tambi has over 30 years of executive management experience with companies such as IVAX Corporation, Fujisawa Pharmaceutical Company USA, LyphoMed Inc., and Bristol-Myers International Group.

Kenneth Abramowitz

Mr. Kenneth S. Abramowitz serves as an Independent Director of Akorn Inc., since May 2010. Mr. Abramowitz is a co-founder and Managing General Partner of NGN Capital. He joined NGN Capital from The Carlyle Group in New York where he was Managing Director from 2001 to 2003, focused on U.S. buyout opportunities in the healthcare industry. Prior to that, Mr. Abramowitz worked as an Analyst at Sanford C. Bernstein & Company where he covered the medical supply, hospital management and Health Maintenance Organization (HMO) industries for 23 years. Mr. Abramowitz earned a B.A. from Columbia University in 1972 and an M.B.A. from Harvard Business School in 1976. Mr. Abramowitz currently sits on the Board of Directors of EKOS Corporation, OptiScan Biomedical Corporation, Cerapedics, Inc., Valtech Cardio and Small Bone Innovations, Inc. He previously served as a director at Option Care, Inc., Sightline Technologies Ltd and Power Medical Interventions, as well as MedPointe and ConnectiCare Holdings, Inc.

Adrienne Graves

Dr. Adrienne L. Graves, Ph.D., serves as an Independent Director of Akorn Inc. From 2002 to 2010, Dr. Graves was President and Chief Executive Officer of Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. She joined Santen Inc. in 1995 as Vice President of Clinical Affairs to initiate the company's clinical development efforts in the U.S. Prior to joining Santen Inc., Dr. Graves spent nine years with Alcon Laboratories, Inc. in various roles. She currently serves on the Boards of TearLab Corporation, Encore Vision, the American Academy of Ophthalmology Foundation, the Pan-American Ophthalmology Foundation, the American Association for Cataract and Refractive Surgery, the Glaucoma Research Foundation, KeepYourSight Foundation, the Corporation Committee for the Brown University Medical School, Aerpio Therapeutics, Himalayan Cataract Project and the Advisory Board for Amach Capital Partners. Dr. Graves also co-founded Ophthalmic Women Leaders and Glaucoma 360. She received her B.A. in Psychology with honors from Brown University, her PhD in Psychobiology from the University of Michigan and completed a postdoctoral fellowship in visual neuroscience at the University of Paris.

Ronald Johnson

Mr. Ronald M. Johnson serves as an Independent Director of Akorn Inc., since May 2003. Mr. Johnson is the president of Becker & Associates Consulting, which provides consulting services to the pharmaceutical, biologics and medical device industries on United States Food and Drug Administration (“FDA”) regulatory requirements. Previously, Mr. Johnson was Executive Vice President of The Lewin Group, a subsidiary of Quintiles Transnational, Inc., which provides various healthcare consulting services to state and federal governments, healthcare insurers and healthcare institutions. Prior to joining The Lewin Group, Mr. Johnson served as Executive Vice President of Quintiles Consulting, a business unit of Quintiles Transnational, Inc. from 1997 to 2006. Quintiles Consulting provides consulting services to the pharmaceutical, medical device, biologic and biotechnology industries in their efforts to meet FDA regulatory requirements. Mr. Johnson also spent 30 years with the FDA, holding various senior level positions primarily in the compliance and enforcement areas.

Steven Meyer

Mr. Steven J. Meyer, CPA, serves as an Independent Director of Akorn Inc. Since 2005, Mr. Meyer has served as the Chief Financial Officer of JVM Realty, a private firm specializing in the acquisition, re-positioning and management of multi-family housing for qualified investors. Mr. Meyer sits on the Board of Directors for INSYS Therapeutics. Mr. Meyer also served as the Corporate Treasurer and International Controller and VP of Global Operations during a 23-year career at Baxter International, Inc.

Alan Weinstein

Mr. Alan D. Weinstein serves as an Independent Director of Akorn Inc. Since 2000, Mr. Weinstein has provided consulting services to supplier clients in the areas of hospital organization, hospital operations, and working with group purchasing organizations. Previously, Mr. Weinstein was the Founder and President of Premier, Inc., an organization which provides various shared services to member hospitals. Mr. Weinstein serves as a director on the boards of Vascular Pathways, Inc., Precyse Solutions, SutureExpress and OpenMarkets.

Chris Hodges

Basic Compensation

Name Fiscal Year Total

John Kapoor

2,083

Rajat Rai

1,637,450

Timothy Dick

532,500

Bruce Kutinsky

590,237

Mark Silverberg

434,823

Joseph Bonaccorsi

496,128

John Sabat

450,816

Brian Tambi

--

Kenneth Abramowitz

--

Adrienne Graves

--

Ronald Johnson

--

Steven Meyer

--

Alan Weinstein

--

Chris Hodges

--
As Of 30 Dec 2013

Options Compensation

Search Stocks